Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension

NCT01122251 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

441

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Lercanidipine + Valsartan
DRUG: Lercanidipine or Valsartan
DRUG: Placebo

Sponsor

LG Life Sciences